DC Vaccines Targeting HPV16/18 E6/E7 Protein to Regress CINI/CIN2

Clinical trial NCT03870113 · UNKNOWN

Trial details

NCT number: NCT03870113
Sponsor: Shenzhen People's Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Cervical Intraepithelial Neoplasia

Start date: 2019-04-01
Primary completion: 2022-03-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.